Study Evaluating Pantoprazole in Adolescents With GERD

• Status: Completed
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is characterize the PK profile of single and multiple doses of pantoprazole in adolescents aged 12 to 16 years with Gastroesophageal Reflux Disease (GERD).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
• Treatments: Pantoprazole

Criteria

Inclusion Criteria:

• 12-16 years old

• clinical diagnosis of GERD

• ability to swallow tablets

Exclusion Criteria:

• GI or malabsorption disorders

• chronic use of warfarin

• positive pregnancy test